within Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H02A_CorticosteroidsForSystemicUsePlain.H02AB07_Prednisone;

model Prednisone
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.82,
    Cl = 3.111111111111111e-06,
    adminDuration = 600,
    adminMass = 20 / 1000000,
    adminCount = 1,
    Vd = 0.0005600000000000001,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.041666666666666664,
    Tlag = 10.200000000000001);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Prednisone</td></tr><tr><td>ATC code:</td><td>H02AB07</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>20</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.56</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.16</td><td>L/h/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Prednisone is a synthetic glucocorticoid corticosteroid drug used primarily to suppress the immune system and reduce inflammation in conditions such as asthma, rheumatoid arthritis, allergic disorders, and autoimmune diseases. It is also sometimes used in certain cancers as part of the treatment. Prednisone is an approved and widely used medication in current medical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers following a single oral dose.</p><h4>References</h4><ol><li><p>de Truchis, C, et al., &amp; Boyer, O (2023). Prednisolone pharmacokinetics after oral prednisone administration in paediatric patients with kidney transplant. <i>British journal of clinical pharmacology</i> 89(5) 1532–1540. DOI:<a href=\"https://doi.org/10.1111/bcp.15610\">10.1111/bcp.15610</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36510685/\">https://pubmed.ncbi.nlm.nih.gov/36510685</a></p></li><li><p>Romano-Aguilar, M, et al., &amp; Romano-Moreno, S (2020). Population pharmacokinetics of mycophenolic acid in Mexican patients with lupus nephritis. <i>Lupus</i> 29(9) 1067–1077. DOI:<a href=\"https://doi.org/10.1177/0961203320931567\">10.1177/0961203320931567</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32539658/\">https://pubmed.ncbi.nlm.nih.gov/32539658</a></p></li><li><p>Velickovic-Radovanovic, R, et al., &amp; Jankovic, SM (2010). Population pharmacokinetics of tacrolimus in kidney transplant patients. <i>International journal of clinical pharmacology and therapeutics</i> 48(6) 375–382. DOI:<a href=\"https://doi.org/10.5414/cpp48375\">10.5414/cpp48375</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20497746/\">https://pubmed.ncbi.nlm.nih.gov/20497746</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.H.H02AB07 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Prednisone;
